6, 2025 (HealthDay News) -- Among privately insured U.S. adolescents who identified as transgender and gender-diverse (TGD), receipt of puberty blockers and hormones was rare from 2018 to 2022 ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果当前正在显示可能无法访问的结果。
隐藏无法访问的结果